Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bluejay Diagnostics, Inc. - Common Stock (NQ:BJDX)

0.8274 +0.0173 (+2.14%)
Delayed Quote Updated: 12:55 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bluejay Diagnostics, Inc. - Common Stock

News headline image
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
SYMON-II Clinical Validation Dataset Represents a Key Milestone as Bluejay Advances the Symphony™ IL-6 Test Toward Regulatory Submission 
From Bluejay Diagnostics
Via ACCESS Newswire
News headline image
NASDAQ Stocks Under $1: FNGR, DUO, EPOW, CYAB in Focus Now!
Via AB Newswire
Topics Artificial Intelligence
News headline image
Bullish Volume: RITR, IGC, BJDX, CISS Lead Active Sub-$1 Stocks to Watch
Via AB Newswire
Topics Artificial Intelligence Economy Fraud
News headline image
TOMI Environmental (NASDAQ: TOMZ) Military-Grade SteraMist® Technology for Pathogen Prevention – More Stocks Inside
Via AB Newswire
News headline image
Loop Industries (NASDAQ: LOOP) – Roth Capital Bullish, CEO & Board Buy Big as Twist™ Gains Global Traction – More Stocks Inside
Via AB Newswire
Topics Economy
Bitech Technologies (OTCQB: BTTC) Appoints Montgomery Bannerman to Drive Strategic Growth in Renewable Energy – see other stocks inside….
Via AB Newswire
Topics Energy
BioMedNewsBreaks — Bluejay Diagnostics Inc. (NASDAQ: BJDX) Closes $8.75M Underwritten Public Offering
Via Investor Brand Network
BioMedNewsBreaks — Bluejay Diagnostics Inc. (NASDAQ: BJDX) Secures ~$2.2M in Private Placement
Via Investor Brand Network
News headline image
Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022
From Bluejay Diagnostics, Inc.
Via GlobeNewswire
News headline image
Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
From Bluejay Diagnostics, Inc.
Via GlobeNewswire
BioMedNewsBreaks – Bluejay Diagnostics Inc. (NASDAQ: BJDX) Announces Continued Advancement of Symphony IL-6 Test
Via Investor Brand Network
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.